Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19Shruti Gupta, Sushrut S. Waikar, Wei Wang et al.|JAMA Internal Medicine|2020Cited by 555
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trialThomas L Holland, Robert C. Hyzy, Nicole Engen et al.|The Lancet Respiratory Medicine|2022Cited by 127